PLAT and Stroke: It has been over 25 years since the publication of the National Institute of Neurological Disorders and Stroke (NINDS) tPA trial (3), the first large positive clinical trial of recombinant tissue plasminogen activator (tPA or alteplase) in ischaemic stroke patients.